UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000058092
Receipt number R000066391
Scientific Title Hepatolithiasis after pancreaticoduodenectomy
Date of disclosure of the study information 2025/06/06
Last modified on 2025/06/05 15:24:40

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Hepatolithiasis after pancreaticoduodenectomy

Acronym

Hepatolithiasis after pancreaticoduodenectomy

Scientific Title

Hepatolithiasis after pancreaticoduodenectomy

Scientific Title:Acronym

Hepatolithiasis after pancreaticoduodenectomy

Region

Japan


Condition

Condition

Hepatolithiasis that occurred after pancreaticoduodenectomy

Classification by specialty

Hepato-biliary-pancreatic surgery

Classification by malignancy

Malignancy

Genomic information

YES


Objectives

Narrative objectives1

The aim of this study is to investigate the risk factors and appropriate treatment for the hepatolithiasis after pancreaticoduodenectomy.

Basic objectives2

Safety,Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

1. To evaluate the risk factors for hepatolithiasis after pancreaticoduodenectomy
2. To evaluate the appropriate treatment for hepatolithiasis after pancreaticoduodenectomy

Key secondary outcomes



Base

Study type

Observational


Study design

Basic design


Randomization


Randomization unit


Blinding


Control


Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms


Purpose of intervention


Type of intervention


Interventions/Control_1


Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit


Not applicable

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

Patients who underwent pancreaticoduodenectomy at our institution

Key exclusion criteria

None

Target sample size

314


Research contact person

Name of lead principal investigator

1st name Masahide
Middle name
Last name Hiyoshi

Organization

Miyazaki Medical Association Hospital

Division name

Department of Surgery

Zip code

880-2102

Address

1173 Arita, Miyazaki-city, Miyazaki, Japan

TEL

+81-985-77-9101

Email

mhiyoshi@med.miyazaki-u.ac.jp


Public contact

Name of contact person

1st name Masahide
Middle name
Last name Hiyoshi

Organization

Miyazaki Medical Association Hospital

Division name

Department of Surgery

Zip code

880-2102

Address

1173 Arita, Miyazaki-city, Miyazaki, Japan

TEL

+81-985-77-9101

Homepage URL


Email

mhiyoshi@med.miyazaki-u.ac.jp


Sponsor or person

Institute

Miyazaki Medical Association Hospital

Institute

Department

Personal name



Funding Source

Organization

None

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Research Ethics Committee, Faculty of Medicine, University of Miyazaki

Address

5200 Kihara, Kiyotake Miyazaki

Tel

+81-985-85-9403

Email

rinken@med.miyazaki-u.ac.jp


Secondary IDs

Secondary IDs

YES

Study ID_1

#O-1502

Org. issuing International ID_1

Research Ethics Committee, Faculty of Medicine, University of Miyazaki

Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2025 Year 06 Month 06 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled

314

Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

No longer recruiting

Date of protocol fixation

2023 Year 12 Month 22 Day

Date of IRB

2024 Year 01 Month 19 Day

Anticipated trial start date

2024 Year 01 Month 19 Day

Last follow-up date

2024 Year 12 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information

None


Management information

Registered date

2025 Year 06 Month 05 Day

Last modified on

2025 Year 06 Month 05 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000066391